Johannes Kepler

Nicox First Half 2021 Financial Results and Business Update

Retrieved on: 
Monday, September 27, 2021
Mont Blanc, Kepler, Intraocular pressure, Johannes Kepler, ODD, Food, Therapy, NCX, Review, NDA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Euronext Paris, 470, Glaucoma, Press release, Fluticasone, FDA, Patient, Bausch & Lomb, Vichy, Compartment, Allergic conjunctivitis, Blepharitis, Ocular hypertension, New Drug Application, Company, LLC, Fera, COX, COVID-19, Anti-transglutaminase antibodies, Nightclub, Animal, Medical device, Pharmaceutical industry

Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today reported the financial results for Nicox SA and its subsidiaries (the Nicox Group) for the six months ending June 30, 2021 and provided an update on recent events as well as progress on key programs.

Key Points: 
  • Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today reported the financial results for Nicox SA and its subsidiaries (the Nicox Group) for the six months ending June 30, 2021 and provided an update on recent events as well as progress on key programs.
  • Net revenue1 for the first half of 2021 was 1.3 million (including 1.2 million in royalty revenue) versus 2.4 million (including 1.4 million in royalty revenue) for the first half of 2020.
  • Operating expenses for the first half of 2021 were 13.3 million compared to 10.2 million for the first half of 2020.
  • As of June 30, 2021, the Nicox Group had cash and cash equivalents of 36.5 million, as compared with 42.0 million at March 31, 2021 and 47.2 million at December 31, 2020.

Nicox Announces Results from the NCX 4251 Phase 2b Mississippi Blepharitis Trial

Retrieved on: 
Thursday, September 23, 2021
Kepler, Intraocular pressure, Johannes Kepler, Data analysis, Food, Therapy, Asthma, Dexamethasone, NCX, Allergic rhinitis, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Duane syndrome, Euronext Paris, Fluticasone, Patient, Bausch & Lomb, Compartment, Allergic conjunctivitis, Eyelid, Blepharitis, LLC, Ophthalmology, COX, Glaucoma, Pharmaceutical industry

Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today announced the results from its Mississippi Phase 2b clinical trial evaluating once-daily dosed NCX 4251, fluticasone propionate ophthalmic suspension 0.1%, against placebo in patients with acute exacerbations of blepharitis.

Key Points: 
  • Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today announced the results from its Mississippi Phase 2b clinical trial evaluating once-daily dosed NCX 4251, fluticasone propionate ophthalmic suspension 0.1%, against placebo in patients with acute exacerbations of blepharitis.
  • NCX 4251 was found to be safe and well-tolerated over 14 days treatment, with no serious adverse events, and all of the adverse events for the NCX 4251 treatment arm were mild.
  • Mississippi was a Phase 2b clinical trial, which recruited 224 patients at multiple clinical centers in the U.S., evaluating once-daily dosed NCX 4251, fluticasone propionate ophthalmic suspension 0.1%, versus placebo in patients with acute exacerbations of blepharitis.
  • Nicox and Ocumension Therapeutics have entered into an exclusive license agreement for the development and commercialization of NCX 4251 for blepharitis in the Chinese market.

Payer announces two new board appointments

Retrieved on: 
Thursday, September 16, 2021
Kepler, Financial technology, Creative, Automation, Goldman Sachs, Norwest Venture Partners, CEO, Board, AP2, Partner (business rank), Director, Johannes Kepler, Enterprise, Merrill (company), SEB, CMO, API, Swedish financial transaction tax, Leadership, Online shopping, Management

Payer is a Swedish payments company primarily for the European B2B market.

Key Points: 
  • Payer is a Swedish payments company primarily for the European B2B market.
  • It provides end-to-end payment solutions for enterprise companies within verticals such as manufacturing, e-commerce, real estate and financial services among others.
  • "I'm thrilled to have both Kai-Stefan and Dominik joining Payer's board.
  • They will both contribute to accelerate Payer's journey to become a global leader in B2B payments", said Peder Berge, CEO and founder of Payer.

Payer announces two new board appointments

Retrieved on: 
Thursday, September 16, 2021
Kepler, Financial technology, Creative, Automation, Goldman Sachs, Norwest Venture Partners, CEO, Board, AP2, Partner (business rank), Director, Johannes Kepler, Enterprise, Merrill (company), SEB, CMO, API, Swedish financial transaction tax, Leadership, Online shopping, Management

Payer is a Swedish payments company primarily for the European B2B market.

Key Points: 
  • Payer is a Swedish payments company primarily for the European B2B market.
  • It provides end-to-end payment solutions for enterprise companies within verticals such as manufacturing, e-commerce, real estate and financial services among others.
  • "I'm thrilled to have both Kai-Stefan and Dominik joining Payer's board.
  • They will both contribute to accelerate Payer's journey to become a global leader in B2B payments", said Peder Berge, CEO and founder of Payer.

Pipeliner Announces the Release of Kepler and New Project Management Capabilities to Increase CRM Productivity

Retrieved on: 
Thursday, September 2, 2021
Kepler, CEO, Software, LONI Pipeline, Solar System, Automation, Commerce, Planet, Heart, Organization, CRM, Johannes Kepler, Sales

LOS ANGELES, Sept. 2, 2021 /PRNewswire/ -- Pipeliner CRM , the leading sales enablement tool and CRM software, today announced new project management capabilities and the release of key account management functionality in its latest version, 4.0 Kepler.

Key Points: 
  • LOS ANGELES, Sept. 2, 2021 /PRNewswire/ -- Pipeliner CRM , the leading sales enablement tool and CRM software, today announced new project management capabilities and the release of key account management functionality in its latest version, 4.0 Kepler.
  • Through it, Pipeliner brings together Salesforce Automation and key account management, uniting each under the umbrella of project management, creating a single, unified revenue engine for all sized organizations.
  • Pipeliner is the only CRM solution available that can support sales in its totality.
  • Key account management, on the other hand, is focused on the "farmer" approach, which cares for and grows existing customers.

Affluent Medical : Liquidity contract implementation with Kepler Cheuvreux.

Retrieved on: 
Monday, June 14, 2021
Kepler Cheuvreux, Johannes Kepler, Liquidity, Christians, Writers, Astronomy

Affluent Medical : Liquidity contract implementation with Kepler Cheuvreux.

Key Points: 
  • Affluent Medical : Liquidity contract implementation with Kepler Cheuvreux.
  • Affluent Medical, a French medtech specialising in the international development and industrial scale-up of innovative medical prostheses, at a clinical stage, to treat urinary incontinence and cardiac mitral valve pathology, today announces that it has entered into a liquidity contract with Kepler Cheuvreux to manage Affluent Medical's shares listed on Euronext Paris.
  • The following resources will be allocated to the liquidity account:
    The execution of the liquidity contract may be suspended:
    By Affluent Medical, in the event that Kepler Cheuvreux has not made reasonable efforts to fulfil its obligations;
    By Kepler Cheuvreux, when the information brought to its attention makes it impossible for it to continue to fulfil its obligations;
    By Kepler Cheuvreux, when the amounts due to Kepler Cheuvreux under the liquidity contract have not been paid;
    Under the conditions set out in Article 5 of AMF Decision No.
  • The liquidity contract may be terminated:
    At any time by Affluent Medical with two (2) working days notice;
    At any time by Kepler Cheuvreux subject to thirty (30) calendar days' notice;
    Without notice and without formality if the shares are transferred to another stock market.

Diving into the Third Order in Simulacra From Jean Baudrillard to the first Global NFT Cryptoart Exhibition by CryptoArt.Ai in Shanghai

Retrieved on: 
Thursday, June 10, 2021
Astronomy, Articles, Academic disciplines, Copernican Revolution, Cosmologists, Johannes Kepler, Kepler space telescope, Simulacrum, The Universe, Universe

Feng Han - "When Nothing surfaces in signs, when Nothingness emerges at the very heart of the sign system, that is the fundamental event of art. The poetic operation is to make Nothingness rises from the power of signs - not banality or indifference towards reality but radical illusion." ---- The Conspiracy of Art, 1996, Jean Baudrillard

Key Points: 
  • The Kepler telescope has travelled in the universe for 9.6 years, discovered 2,662 planets, recorded 61 supernovas, observed 530,506 stars.
  • When Ouchhh reorganise and reconfigured the data and applied artificial intelligence to run it, they achieved this artwork.
  • The 'translation' is realised by machine learning, and presented a simulated universe trapped inside of a cube.
  • People's organism bodies are still living in the real world, but in the society consists of 'bodies', everything turned into simulacra.

Kepler Communications raises oversubscribed $60M Series B for satellite communications network

Retrieved on: 
Wednesday, June 9, 2021
Astronomy, Spaceflight, Spacecraft, Satellite broadcasting, Kepler Communications, Earth orbits, Kepler space telescope, Communications satellite, Satellite, Johannes Kepler, Low Earth orbit

Toronto, Ontario, June 09, 2021 (GLOBE NEWSWIRE) -- Space company Kepler Communications has raised an oversubscribed US$60M Series B to provide it with a capital injection for the continued scaling of its on-orbit satellite communications network.

Key Points: 
  • Toronto, Ontario, June 09, 2021 (GLOBE NEWSWIRE) -- Space company Kepler Communications has raised an oversubscribed US$60M Series B to provide it with a capital injection for the continued scaling of its on-orbit satellite communications network.
  • Kepler is charging forward in the space race to develop a Low Earth Orbit (LEO) satellite communication network.
  • Kepler designs, builds, and operates satellites that are 1/10th the size and cost of alternatives to provide satellite communication services.
  • Additionally, the funds from the Series B will be used to enhance the size and caliber of the team at Kepler Communications.

Kymeta Interoperability with Kepler LEO Satellites Promises Powerful Connectivity of the Future with Kymeta™ u8 Terminal

Retrieved on: 
Tuesday, March 23, 2021
Software, Mobile, Wireless, Networks, Other Defense, Hardware, Data management, Technology, Defense, Satellite, Other Technology, Aerospace, Telecommunications, Manufacturing, Inuvik, Spacecraft, Astronomy, Kymeta, Metamaterials, Kepler space telescope, Johannes Kepler, Uncrewed spacecraft, Kepler, Kymeta, Kepler Communications Inc.

View the full release here: https://www.businesswire.com/news/home/20210323005226/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20210323005226/en/
    Image of the Kymeta u8 Terminal in Inuvik, Canada during testing with Kepler LEO Satellites.
  • (Photo: Business Wire)
    In 2020, Kepler was selected for an extended u8 beta trial to capture the extended Northern winter in Inuvik, Canada.
  • Frequent revisit times from the Kepler LEO satellites combined with the local environment of unprotected cold weather, snow, and ice provided a unique testing opportunity for the latest Kymeta technology.
  • Kymeta believes the collaboration with Kepler and further testing is instrumental to providing reliable connectivity and superior benefits to customers.

Kepler and Infectious Media Join Forces to Create Global Innovation Leader

Retrieved on: 
Thursday, December 3, 2020
Spacecraft, Astronomy, Copernican Revolution, Cosmologists, Johannes Kepler, Kepler space telescope, Kepler, Uncrewed spacecraft

This unites two transformative firms to create an industry leader with true global reach.

Key Points: 
  • This unites two transformative firms to create an industry leader with true global reach.
  • As experts in these areas, Kepler and Infectious Media have both grown in 2020 while less technologically advanced marketing groups declined.
  • Infectious Media will retain its brand name in the immediate term and adopt the Kepler name in a staged process.
  • For more information from Kepler, contact:
    Infectious Media is a digital media specialist with offices in London and Singapore.